GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now gaining a major focus in healthcare investigation, largely due to its impressive impact on treating conditions such as adult-onset diabetes and obesity. Recent trials have demonstrated that beyond glucose management, GLP-1 medications offer promise for cardiovascular function and pe